P Pacher, JS Beckman, L Liaudet - Physiological reviews, 2007 - journals.physiology.org
The discovery that mammalian cells have the ability to synthesize the free radical nitric oxide (NO) has stimulated an extraordinary impetus for scientific research in all the fields of …
L Virag, C Szabó - Pharmacological reviews, 2002 - ASPET
Poly (ADP-ribose) polymerase-1 (PARP-1) is a member of the PARP enzyme family consisting of PARP-1 and several recently identified novel poly (ADP-ribosylating) enzymes …
NJ Curtin, C Szabo - Molecular aspects of medicine, 2013 - Elsevier
The aim of this article is to describe the current and potential clinical translation of pharmacological inhibitors of poly (ADP-ribose) polymerase (PARP) for the therapy of …
O Surova, B Zhivotovsky - Oncogene, 2013 - nature.com
The consequences of DNA damage depend on the cell type and the severity of the damage. Mild DNA damage can be repaired with or without cell-cycle arrest. More severe and …
P Jagtap, C Szabó - Nature reviews Drug discovery, 2005 - nature.com
Abstract Poly (ADP-ribose) polymerases (PARPs) are involved in the regulation of many cellular functions. Three consequences of the activation of PARP1, which is the main isoform …
PO Hassa, MO Hottiger - Cellular and Molecular Life Sciences CMLS, 2002 - Springer
Mammalian poly (ADP-ribose) polymerase 1 (PARP-1) is an abundant nuclear chromatin- associated protein and belongs to a large family of enzymes that catalyzes the transfer of …
P Pacher, C Szabó - Cardiovascular drug reviews, 2007 - Wiley Online Library
Accumulating evidence suggests that the reactive oxygen and nitrogen species are generated in cardiomyocytes and endothelial cells during myocardial ischemia/reperfusion …
Patients with diabetes exhibit a high incidence of diabetic cardiomyopathy and vascular complications, which underlie the development of retinopathy, nephropathy, and neuropathy …
Falciparum malaria is a complex disease with no simple explanation, affecting organs where the parasite is rare as well as those organs where it is more common. We continue to argue …